(Q37980056)

26 August 2017

title

Respiratory syncytial virus infection and immunity (English)

1 reference

26 August 2017

Susan M Bueno

2

0 references

Alexis M Kalergis

series ordinal

5

object named as

Alexis M Kalergis

1 reference

26 August 2017

4

Claudia A Riedel

1 reference

26 August 2017

3

Leandro J Carreño

1 reference

26 August 2017

Pablo A González

1

1 reference

26 August 2017

language of work or name

1 reference

31 January 2012

1 reference

Reviews in Medical Virology

26 August 2017

published in

1 reference

26 August 2017

volume

22

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

230-244

1 reference

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

26 August 2017

cites work

1 reference

Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection

21 January 2018

1 reference

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 January 2018

1 reference

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

21 January 2018

1 reference

Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review

21 January 2018

1 reference

Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection

21 January 2018

1 reference

Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells

21 January 2018

1 reference

Immunity to and frequency of reinfection with respiratory syncytial virus

21 January 2018

1 reference

Basic epidemiology and immunopathology of RSV in children.

21 January 2018

1 reference

Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis

21 January 2018

1 reference

Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.

21 January 2018

1 reference

The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes

21 January 2018

1 reference

Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice

21 January 2018

1 reference

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.

21 January 2018

1 reference

Host immunity during RSV pathogenesis

21 January 2018

1 reference

Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis

21 January 2018

1 reference

The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.

21 January 2018

1 reference

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

21 January 2018

1 reference

Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections.

21 January 2018

1 reference

Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection

21 January 2018

1 reference

The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice

21 January 2018

1 reference

Respiratory viral infections in patients with chronic, obstructive pulmonary disease

21 January 2018

1 reference

Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract

21 January 2018

1 reference

Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection

21 January 2018

1 reference

Modulation of the dendritic cell-T-cell synapse to promote pathogen immunity and prevent autoimmunity

21 January 2018

1 reference

Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.

21 January 2018

1 reference

RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity

21 January 2018

1 reference

Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.

21 January 2018

1 reference

Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection

21 January 2018

1 reference

Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections

21 January 2018

1 reference

Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response

21 January 2018

1 reference

Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells.

21 January 2018

1 reference

The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific.

21 January 2018

1 reference

Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells

21 January 2018

1 reference

Antiviral signaling through pattern recognition receptors

21 January 2018

1 reference

Dendritic cells and the control of immunity

21 January 2018

1 reference

Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus

21 January 2018

1 reference

Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells

21 January 2018

1 reference

Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3

21 January 2018

1 reference

Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells

21 January 2018

1 reference

Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus

21 January 2018

1 reference

Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells

21 January 2018

1 reference

Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus

21 January 2018

1 reference

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus

21 January 2018

1 reference

Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells

21 January 2018

1 reference

Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection

21 January 2018

1 reference

IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.

21 January 2018

1 reference

STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection

21 January 2018

1 reference

Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node

21 January 2018

1 reference

The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections

21 January 2018

1 reference

Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections

21 January 2018

1 reference

Local CD11c+ MHC class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process

21 January 2018

1 reference

Subversion of pulmonary dendritic cell function by paramyxovirus infections

21 January 2018

1 reference

Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection

21 January 2018

1 reference

Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus

21 January 2018

1 reference

Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells

21 January 2018

1 reference

Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines

21 January 2018

1 reference

Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase

21 January 2018

1 reference

Regulation of STAT signaling in mouse bone marrow derived dendritic cells by respiratory syncytial virus.

21 January 2018

1 reference

CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC.

21 January 2018

1 reference

T-cell activation through immunological synapses and kinapses

21 January 2018

1 reference

T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC

21 January 2018

1 reference

Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact

21 January 2018

1 reference

A role for the immunological synapse in lineage commitment of CD4 lymphocytes

21 January 2018

1 reference

Modulation of immunological synapse by membrane-bound and soluble ligands.

21 January 2018

1 reference

Synergistically upregulated interleukin-10 production in cocultures of monocytes and T cells after stimulation with respiratory syncytial virus

21 January 2018

1 reference

"Bystander" recruitment of systemic memory T cells delays the immune response to respiratory virus infection

21 January 2018

1 reference

T helper 1 background protects against airway hyperresponsiveness and inflammation in guinea pigs with persistent respiratory syncytial virus infection

21 January 2018

1 reference

Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17.

21 January 2018

1 reference

Comparison of cytokine responses in nasopharyngeal aspirates from children with viral lower respiratory tract infections.

21 January 2018

1 reference

T helper lymphocyte response to respiratory syncytial virus and its components in patients with respiratory allergy and nonatopic controls

21 January 2018

1 reference

Distinct types of lung disease caused by functional subsets of antiviral T cells

21 January 2018

1 reference

IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.

21 January 2018

1 reference

Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein

21 January 2018

1 reference

IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.

21 January 2018

1 reference

Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology

21 January 2018

1 reference

Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells

21 January 2018

1 reference

Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines

21 January 2018

1 reference

Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies

21 January 2018

1 reference

Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection

21 January 2018

1 reference

Inhibition of CD8+ T lymphocytes attenuates respiratory syncytial virus-enhanced allergic inflammation

21 January 2018

1 reference

Epitope-Specific Regulatory CD4 T Cells Reduce Virus-Induced Illness while Preserving CD8 T-Cell Effector Function at the Site of Infection

21 January 2018

1 reference

Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities

21 January 2018

1 reference

CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection

21 January 2018

1 reference

Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection

21 January 2018

1 reference

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

21 January 2018

1 reference

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

21 January 2018

1 reference

Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses

21 January 2018

1 reference

Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells

21 January 2018

1 reference

Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice

21 January 2018

1 reference

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice

21 January 2018

1 reference

Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells

21 January 2018

1 reference

Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells.

21 January 2018

1 reference

Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells

21 January 2018

1 reference

Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes.

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

21 January 2018

1 reference

RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.

21 January 2018

1 reference

Inhibition of respiratory viruses by nasally administered siRNA.

21 January 2018

1 reference

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

21 January 2018

1 reference

A role for immune complexes in enhanced respiratory syncytial virus disease

21 January 2018

1 reference

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

21 January 2018

1 reference

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

21 January 2018

1 reference

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

21 January 2018

1 reference

New generation live vaccines against human respiratory syncytial virus designed by reverse genetics

21 January 2018

1 reference

Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro

21 January 2018

1 reference

Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus

21 January 2018

1 reference

The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo

21 January 2018

1 reference

A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.

21 January 2018

1 reference

Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge.

21 January 2018

1 reference

Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine

21 January 2018

1 reference

Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium

21 January 2018

1 reference

Use of genetically modified bacteria to modulate adaptive immunity.

21 January 2018

1 reference

Protective effect of a RSV subunit vaccine candidate G1F/M2 was enhanced by a HSP70-Like protein in mice

21 January 2018

1 reference

Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000181.PUB3

12 January 2024

Identifiers

DOI

10.1002/RMV.1704

1 reference

26 August 2017

1 reference